发明名称 |
CONTROLLED RELEASE FORMULATION COMPRISING GNRH-II |
摘要 |
A pharmaceutical formulation for the controlled release of a therapeutic peptide or a salt thereof, which peptide has the sequence pyroGlu-His-Trp-Ser-Xaa<1>-Gly-Xaa<2>-Xaa<3>-Pro-Gly-NH2 wherein Xaa<1> is His or Tyr, Xaa<2> is Trp or Leu, and Xaa<3> is Tyr or Arg, provided that when Xaa<1> is Tyr and Xaa<2> is Leu, then Xaa<3> is not Arg, and which formulation further comprises a pharmaceutically acceptable biodegradable polymer. The formulation can be used for treating bone and prostate disorders.
|
申请公布号 |
WO0032218(A1) |
申请公布日期 |
2000.06.08 |
申请号 |
WO1999GB04045 |
申请日期 |
1999.12.02 |
申请人 |
FERRING BV;QI, STEVE;AKINSANYA, KAREN;HAYWARD, AMANDA |
发明人 |
QI, STEVE;AKINSANYA, KAREN;HAYWARD, AMANDA |
分类号 |
A61K9/50;A61K9/16;A61K38/00;A61K38/09;A61K47/34;A61P3/10;A61P13/08;A61P19/00;A61P19/10;A61P35/00;C07K7/23;C07K14/59;(IPC1-7):A61K38/09 |
主分类号 |
A61K9/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|